Enhanced Pharmaceutical Compositions for Gynecological Diseases Using Sarcodon Aspratus Extracts

The present invention discloses novel pharmaceutical compositions and systems that improve the efficacy, safety, and convenience of Sarcodon aspratus extracts in preventing and treating gynecological diseases, thereby providing better treatment outcomes and improved quality of life for patients.

The original patent disclosed a pharmaceutical composition containing Sarcodon aspratus extracts for preventing and treating gynecological diseases. However, the existing composition had limitations in terms of absorption rate, efficacy, and potential toxicity. The present invention addresses these limitations by introducing novel formulations, synergistic agents, and diagnostic tools to enhance the therapeutic effects and safety of the extracts.

The inventive concept comprises four main aspects: (1) a system for preventing or treating gynecological diseases with a faster absorption rate, (2) a method for enhancing the efficacy of Sarcodon aspratus extracts using synergistic agents, (3) a pharmaceutical composition with time-release formulation for sustained release of active ingredients, and (4) a system for personalized treatment using diagnostic tools and adjustable dosage formulations. These aspects are designed to provide quicker relief, improved treatment outcomes, and reduced risk of adverse reactions.

The present invention introduces novel and non-obvious improvements to the original patent, including faster absorption rates, synergistic agents, time-release formulations, and personalized treatment systems. These advancements overcome the limitations of the existing composition and provide a significant enhancement in the treatment of gynecological diseases.

Alternative embodiments of the inventive concept may include different synergistic agents, varying time-release formulations, and adaptable diagnostic tools. Additionally, the system could be modified to accommodate different routes of administration, such as topical or injectable formulations.

The enhanced pharmaceutical compositions and systems of the present invention have significant commercial potential in the gynecological disease treatment market. The improved efficacy, safety, and convenience of the compositions are expected to appeal to healthcare providers and patients, leading to increased adoption and market share.